# ERock, Inc.: financial statements, quarterly

EROC · NYSE · CIK 2110029 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eroc.md) · [Financials](/companies/eroc/financials.md) · [Filings](/companies/eroc/filings.md) · [Insiders](/companies/eroc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eroc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [68.5](/filings/0001193125-26-346922.md) | not reported | [39.9](/filings/0001193125-26-346922.md) |
| Operating income | $m | not reported | [(0.5)](/filings/0001193125-26-346922.md) | not reported | [(19.8)](/filings/0001193125-26-346922.md) |
| Income tax | $m | not reported | [0.0](/filings/0001193125-26-346922.md) | not reported | [(0.4)](/filings/0001193125-26-346922.md) |
| Net income | $m | [(15.9)](/filings/0001193125-26-346922.md) | [(8.0)](/filings/0001193125-26-346922.md) | [(17.2)](/filings/0001193125-26-346922.md) | [(3.0)](/filings/0001193125-26-346922.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [(0.06)](/filings/0001193125-26-346922.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | [(0.06)](/filings/0001193125-26-346922.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-12-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Cash and equivalents | $m | [108](/filings/0001193125-26-346922.md) | [627](/filings/0001193125-26-346922.md) |
| Current assets | $m | [217](/filings/0001193125-26-346922.md) | [882](/filings/0001193125-26-346922.md) |
| Total assets | $m | [258](/filings/0001193125-26-346922.md) | [978](/filings/0001193125-26-346922.md) |
| Current liabilities | $m | [241](/filings/0001193125-26-346922.md) | [621](/filings/0001193125-26-346922.md) |
| Total liabilities | $m | [323](/filings/0001193125-26-346922.md) | [721](/filings/0001193125-26-346922.md) |
| Long-term debt | $m | [60.0](/filings/0001193125-26-346922.md) | [0.0](/filings/0001193125-26-346922.md) |
| Shareholders' equity | $m | [0.0](/filings/0001193125-26-346922.md) | [257](/filings/0001193125-26-346922.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Shares

| Line item | Unit | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: |
| Diluted shares (weighted) | millions of shares | [48.2](/filings/0001193125-26-346922.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.